ARCHIVES

In Brief: David Feigal To Head FDA’s Antiviral Division; ODAC To Discuss Melphalan, Amifostine NDAs

This article is from The Cancer Letter archive.

Vol. 18 No. 03 | January 17, 1992

Download PDF Visit The Full Archive

Related Articles

Task Force Members Give Mea Culpa at Congressional Hearing

December 4, 2009

Major Changes In NCI Drug screening Tumor Panels Approved

June 18, 1982

One Flexible Sigmoidoscopy Can Reduce Risk by 31 Percent

September 30, 2011

FDA Issues Final Regs for Mammography Facilities, Personnel

November 7, 1997

CTEP Analyses Proposals For Changes In Cooperative Groups

April 25, 1986

Conferees Agree On $815 Million For NCI In ‘77

July 30, 1976